These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6188548)

  • 21. Plasma expanders in hemorrhagic shock.
    Stacca R; Bertellini E; Piccinini P; Morselli L; Tassi A
    Resuscitation; 1989 Dec; 18(2-3):153-4. PubMed ID: 2479967
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of artificial colloids on blood coagulation during shock stage of severe burn injury.
    Zhou JJ; Xing N; Chen J; Shi JW; Su GL
    Chin Med J (Engl); 2013; 126(17):3334-9. PubMed ID: 24033960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood substitutes.
    Moffitt EA
    Can Anaesth Soc J; 1975 Jan; 22(1):12-9. PubMed ID: 1109702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. To which extent is the clinical use of dextran, gelatin and hydroxyethyl starch influenced by the incidence and severity of anaphylactoid reactions?
    Collins JA; Litwin MS; Lutz H; Klose R; Ring J; Thorén L; Tschirren B; Lundsgaard-Hansen P
    Vox Sang; 1979; 36(1):39-49. PubMed ID: 85370
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical relevance of the effects of plasma expanders on coagulation.
    Levi M; Jonge Ed
    Semin Thromb Hemost; 2007 Nov; 33(8):810-5. PubMed ID: 18175286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of kidney function on the elimination and action of colloidal plasma substitutes].
    Köhler H
    Fortschr Med; 1979 Oct; 97(40):1809-13. PubMed ID: 94298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged Field Care Working Group Fluid Therapy Recommendations.
    Baker BL; Powell D; Riesberg J; Keenan S
    J Spec Oper Med; 2016; 16(1):112-7. PubMed ID: 27045508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood and blood substitutes: current practice.
    Rice CL; Moss GS
    Adv Surg; 1979; 13():93-114. PubMed ID: 391005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.
    Bayer O; Reinhart K; Kohl M; Kabisch B; Marshall J; Sakr Y; Bauer M; Hartog C; Schwarzkopf D; Riedemann N
    Crit Care Med; 2012 Sep; 40(9):2543-51. PubMed ID: 22903091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects and adverse effects of colloid-containing solutions].
    Bergmann H
    Beitr Infusionther Klin Ernahr; 1979; 2():43-50. PubMed ID: 94260
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety of nonblood plasma substitutes: less frequently discussed issues.
    Boldt J
    Eur J Anaesthesiol; 2010 Jun; 27(6):495-500. PubMed ID: 20179599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of blood substitutes in treating shock].
    Koziner VB
    Probl Gematol Pereliv Krovi; 1972 Nov; 17(11):3-8. PubMed ID: 4584751
    [No Abstract]   [Full Text] [Related]  

  • 33. [The influence of different plasma substitutes on blood clotting and platelet function during and after operations (author's transl)].
    Harke H; Thoenies R; Margraf I; Momsen W
    Anaesthesist; 1976 Aug; 25(8):366-73. PubMed ID: 60065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison.
    Bayer O; Reinhart K; Sakr Y; Kabisch B; Kohl M; Riedemann NC; Bauer M; Settmacher U; Hekmat K; Hartog CS
    Crit Care Med; 2011 Jun; 39(6):1335-42. PubMed ID: 21358396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Incidence of anaphylactoid reactions following infusion with colloid volume substitutes].
    Ring J; Seifert J; Struif E; Messmer K; Brendel W
    Chir Forum Exp Klin Forsch; 1977 Apr; ():31-5. PubMed ID: 87295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Binding of drugs to artificial plasma substitutes].
    Borchardt W; Heinzow B; Ziegler A
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():28-30. PubMed ID: 2439455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infusiontherapy with colloidal volumesubstitutes (author's transl)].
    Ring J; Messmer K
    Anaesthesist; 1977 Jun; 26(6):279-87. PubMed ID: 883609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scope and limitations of therapy with plasma substitutes: differential indication for substitutes, blood preparations and electrolyte solutions.
    Reissigl H
    Bibl Haematol; 1969; 33():32-54. PubMed ID: 4914355
    [No Abstract]   [Full Text] [Related]  

  • 40. [Replenishment of circulating blood volume by the use of colloid solutions].
    Franke R
    Anesteziol Reanimatol; 1999; (3):70-6. PubMed ID: 10458044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.